2006•The LancetRequires access

Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison

Christopher Paul Cannon, Sean Curtis, Garret A. FitzGerald, Henry Krum, Amarjot Kaur, James A. Bolognese, Alise S. Reicin, Claire Bombardier, Michael E. Weinblatt, Désirée van der Heijde, Erland Erdmann, Loren Laine

Open publisher page 523 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 523 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Etoricoxib, Medicine, Diclofenac, Rheumatoid arthritis, Osteoarthritis, Internal medicine, Arthritis, Hazard ratio